Aurea Biolabs Private Limited

Aurea Biolabs Private Limited - pharma in Kochi, Kerala, India. FY 2026 financials & compliance.
CIN U15490KL2014PTC036178 Incorporated 14 February 2014 ROC Ernakulam HQ Kochi, Kerala, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹60.59 Cr
▼ 10% YoY
Net profit · FY 2024
₹14.02 Cr
Net margin 23.1%
EBITDA · FY 2024
₹22.78 Cr
EBITDA margin 37.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹25 Cr
Satisfied ₹43.25 Cr
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings

About Aurea Biolabs Private Limited

Data last updated:

Aurea Biolabs Private Limited is a private limited company based in Kochi, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U15490KL2014PTC036178. Its GSTIN is 32AAMCA4537B1Z3 (Kerala). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including John George Nechupadom (Managing Director) and Mariam George (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 27/1025A G – 285 Main Avenue Panampilly Nagar, Kochi, Kerala, India – 682036.

As per the financials filed for FY 2024, the company reported a revenue of ₹60.59 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹14.02 Cr (net margin 23.1%) and EBITDA of ₹22.78 Cr (EBITDA margin 37.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 40% over five years.

The company is associated with 1 brand: Aurea Biolabs. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹43.25 Cr on record. Court records list 9 cases involving the company, including 6 filed by the company; 5 cases are pending. The company has 1 deal on record (1 rights issue); the latest was in March 2016. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is M H Medicus Private Limited with revenue of ₹60.87 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aureabiolabs.com.

Company Details of Aurea Biolabs Private Limited
CIN U15490KL2014PTC036178
Registration Number 036178
Incorporation Date 14 February 2014
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    27/1025A G – 285 Main Avenue Panampilly Nagar, Kochi, Kerala, India – 682036
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Aurea Biolabs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Aurea Biolabs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Aurea Biolabs Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Aurea Biolabs Private Limited

The main business activity of Aurea Biolabs is manufacturing. In detail, this covers food, beverages and tobacco products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC1Food, beverages and tobacco productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Aurea Biolabs Private Limited FY 2024 filings available

Aurea Biolabs Private Limited reported revenue of ₹60.59 Cr (down 10% YoY) for FY 2024.

Revenue · FY 2024
₹60.59 Cr ▼ 10%
Net profit · FY 2024
₹14.02 Cr margin 23.1%
EBITDA · FY 2024
₹22.78 Cr margin 37.6%

Compounded Annual Growth Rate (CAGR) of Aurea Biolabs Private Limited

Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 10%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 10%
5 years · compounded
▲ 47%

Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 40%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Aurea Biolabs Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹22.78 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹14.02 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Aurea Biolabs Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin37.6%••••••••••••••••
Net Profit Margin23.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aurea Biolabs are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Aurea Biolabs Private Limited

Aurea Biolabs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
M H Medicus Private Limited₹60.87 Cr (FY 2025)••••••••46.0%••••New Delhi, Delhi, India
Mars Therapeutics Private Limited₹60.85 Cr (FY 2025)••••••••25.0%••••Hyderabad, Telangana, India
Yacca Lifesciences Private Limited₹60.81 Cr (FY 2024)••••••••39.0%••••Roorkee, Uttarakhand, India
Converge Biotech Private Limited₹60.73 Cr (FY 2024)••••••••-6.0%••••Hyderabad, Telangana, India
Kausikh Therapeutics Private Limited₹60.69 Cr (FY 2025)••••••••8.0%••••Gerugambakkam, Tamil Nadu, India
Aurea Biolabs Private Limited this company₹60.59 Cr (FY 2024)••••••••-10.0%••••Kochi, Kerala, India
Saffron Formulations Private Limited₹60.55 Cr (FY 2025)••••••••16.0%••••Ahmedabad, Gujarat, India
Lok-Beta Pharmaceuticals (India )Private Limited₹60.2 Cr (FY 2024)••••••••40.0%••••Mumbai, Maharashtra, India
Holden Medical Laboratories Private Limited₹59.81 Cr (FY 2025)••••••••3.0%••••Nashik, Maharashtra, India
Deccan Health Care Limited Listed₹59.74 Cr (FY 2024)••••••••33.0%••••Hyderabad, Telangana, India
Systole Remedies Private Limited₹59.68 Cr (FY 2025)••••••••28.0%••••Delhi, India

Peers are the five companies nearest above and the five nearest below Aurea Biolabs by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Aurea Biolabs Private Limited

Aurea Biolabs Private Limited is audited by ELIAS GEORGE & CO for the financial year 2023.

NameStatusAppointment DateCessation Date
ELIAS GEORGE & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Aurea Biolabs Private Limited

Aurea Biolabs has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Chennakattu John GeorgeDirector14 Feb 201412 Years 8 MonthsCurrent
Mariam GeorgeWhole-Time Director20 Sep 20179 Years 0 MonthsCurrent
John George NechupadomManaging Director14 Feb 201412 Years 8 MonthsCurrent

Ownership and Shareholding of Aurea Biolabs Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Aurea Biolabs Private Limited

Open charges
₹25 Cr
Satisfied charges
₹43.25 Cr
Breakdown by lending institutions
Others₹43.25 Cr
Latest charge details
DateLenderAmountStatus
13 Jan 2023Others₹5 CrSatisfied
13 Jan 2023Others₹25 CrSatisfied
14 Jun 2018Others₹5 CrSatisfied
14 Jun 2018Others₹8.25 CrSatisfied

Total charge records: 4 View all charges

Deals & Funding of Aurea Biolabs Private Limited

Aurea Biolabs Private Limited has 1 deal on record (1 rights issue); the latest was in March 2016.

Total deals
1
Rights issue
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2016Rights issue₹99 LakhInvestors: 3 individuals
Premium access

Full deal history

All 1 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Associated Brands with Aurea Biolabs Private Limited

Aurea Biolabs operates one associated brand: Aurea Biolabs. Each brand links to its own profile.

BrandDescriptionWebsite
Nutraceutical ingredient manufacturing for human and animal nutrition sectors.aureabiolabs.com

Employees and EPFO Compliance at Aurea Biolabs Private Limited

Employment history and EPFO contributions of people linked to Aurea Biolabs.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Aurea Biolabs Private Limited

Aurea Biolabs Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Mariam George was appointed as Whole-Time Director on 20 Sep 2017.

Charges
A charge registered on 13 Jan 2023 via Charge ID 100673016 with Others was fully satisfied on 01 Jan 2025.
AGM
Aurea Biolabs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Aurea Biolabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Charges
A charge registered on 14 Jun 2018 via Charge ID 100216520 with Others was fully satisfied on 26 Jul 2023.
Charges
A charge registered on 14 Jun 2018 via Charge ID 100216523 with Others was fully satisfied on 26 Jul 2023.
Charges
A charge registered on 13 Jan 2023 via Charge ID 100673013 with Others was fully satisfied on 15 Mar 2023.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100673013 was registered on 13 Jan 2023.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 100673016 was registered on 13 Jan 2023.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100216520 was registered on 14 Jun 2018.
Charges
A charge with Others amounted to Rs. 8.25 Cr with Charge ID 100216523 was registered on 14 Jun 2018.
Appointed
Mariam George was appointed as Whole-Time Director.
Appointed
Chennakattu John George was appointed as Director.

2 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Aurea Biolabs Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aurea Biolabs Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aurea Biolabs Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Aurea Biolabs Private Limited

Aurea Biolabs has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
32AAMCA4537B1Z3KeralaActive01 Jul 2017
29AAMCA4537B1ZQKarnatakaActive27 Dec 2017
06AAMCA4537B1ZYHaryanaActive20 Sep 2023
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aurea Biolabs Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aurea Biolabs Private Limited

Aurea Biolabs is an active private limited company based in Kochi, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2014 (12+ years old) and is registered under CIN U15490KL2014PTC036178.

Aurea Biolabs reported revenue of ₹60.59 Cr for FY 2024 (down 10% YoY).

Aurea Biolabs has 3 current directors:

Aurea Biolabs reported a net profit of ₹14.02 Cr (net margin 23.1%) and EBITDA of ₹22.78 Cr (EBITDA margin 37.6%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Aurea Biolabs is -10% over three years and 40% over five years. In the latest year (FY 2024) revenue fell 10%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Aurea Biolabs is 32AAMCA4537B1Z3, registered in Kerala. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 29AAMCA4537B1ZQ (Karnataka), 06AAMCA4537B1ZY (Haryana).

The CIN (Corporate Identification Number) of Aurea Biolabs is U15490KL2014PTC036178. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aurea Biolabs has 9 court cases on record: 6 filed by the company. 5 are pending. Most are in the high courts.

Aurea Biolabs was incorporated on 14 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ernakulam.

Aurea Biolabs has 1 deal on record (1 rights issue); the latest was in March 2016.

The peers of Aurea Biolabs by revenue are M H Medicus Private Limited, Mars Therapeutics Private Limited, Yacca Lifesciences Private Limited, Converge Biotech Private Limited, Kausikh Therapeutics Private Limited and 5 more, all in the Pharma industry (Formulations).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available